Paper Details

  1. Home
  2. Paper Details

Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.

Author: DhanukaIda, SimonJames A

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Hypoactive sexual desire disorder (HSDD) is the most common form of female sexual dysfunction. Some theories suggest that HSDD has a neurobiological component linked to neurotransmitter imbalances. Flibanserin is the only FDA-approved treatment of HSDD.
Paper Details　
Original Abstract of the Article :
Hypoactive sexual desire disorder (HSDD) is the most common form of female sexual dysfunction (FSD). Some theories suggest that HSDD has a neurobiological component linked to neurotransmitter imbalances. Flibanserin is the only FDA-approved treatment of HSDD; before its approval, the disorder was of...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1517/14656566.2015.1090426

データ提供：米国国立医学図書館（NLM）

Flibanserin: A New Hope for Hypoactive Sexual Desire Disorder

Sexual desire disorder (HSDD) is a common yet often overlooked condition affecting women. This study examines the potential of [flibanserin], a new drug approved by the FDA for the treatment of [hypoactive sexual desire disorder (HSDD)] in premenopausal women. The study explores the neurobiological mechanisms underlying HSDD and the role of [flibanserin] in addressing these imbalances.

Flibanserin: Addressing a Neglected Area of Women's Health

The researchers highlight the significance of addressing HSDD, which has historically been underdiagnosed and undertreated. The availability of flibanserin offers a new therapeutic option for women struggling with this condition.

A Step Towards Better Sexual Health for Women

This research is a step forward in improving sexual health for women. By providing a targeted treatment option for HSDD, flibanserin has the potential to empower women and improve their overall well-being.

Dr.Camel's Conclusion

Just like camels are known for their endurance and resilience, women facing sexual health challenges deserve compassion and effective treatments. This study shines a light on HSDD and offers a potential solution for improving the lives of women affected by this condition.

Date :
  1. Date Completed 2016-03-14
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

26395164

DOI: Digital Object Identifier

10.1517/14656566.2015.1090426

Related Literature

Article Analysis
・Side Effects of flibanserin
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.